Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Receivables (2018 - 2025)

Viemed Healthcare's Change in Receivables history spans 8 years, with the latest figure at -$1.8 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 14.58% year-over-year to -$1.8 million; the TTM value through Dec 2025 reached -$1.2 million, down 119.07%, while the annual FY2025 figure was -$1.2 million, 119.07% down from the prior year.
  • Change in Receivables reached -$1.8 million in Q4 2025 per VMD's latest filing, down from -$968000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $6.0 million in Q1 2024 to a low of -$2.8 million in Q2 2022.
  • Average Change in Receivables over 5 years is $793700.0, with a median of $480000.0 recorded in 2021.
  • Peak YoY movement for Change in Receivables: surged 598.64% in 2024, then tumbled 7966.67% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $1.8 million in 2021, then plummeted by 77.6% to $397000.0 in 2022, then soared by 32.24% to $525000.0 in 2023, then crashed by 507.62% to -$2.1 million in 2024, then rose by 14.58% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Change in Receivables are -$1.8 million (Q4 2025), -$968000.0 (Q3 2025), and -$240000.0 (Q2 2025).